The Values of Systemic Immune-Inflammation Index and Neutrophil–Lymphocyte Ratio in Predicting Biochemical Recurrence in Patients With Localized Prostate Cancer After Radical Prostatectomy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Values of Systemic Immune-Inflammation Index and Neutrophil–Lymphocyte Ratio in Predicting Biochemical Recurrence in Patients With Localized Prostate Cancer After Radical Prostatectomy
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-06-02
DOI
10.3389/fonc.2022.907625
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Values of Systemic Immune-Inflammation Index and Neutrophil–Lymphocyte Ratio in the Localized Prostate Cancer and Benign Prostate Hyperplasia: A Retrospective Clinical Study
- (2022) Shuo Wang et al. Frontiers in Oncology
- Racial differences in the systemic inflammatory response to prostate cancer
- (2021) Andrew G. Rundle et al. PLoS One
- Impact of systemic Immune–inflammation Index on oncologic outcomes in patients treated with radical prostatectomy for clinically nonmetastatic prostate cancer
- (2021) Pawel Rajwa et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Lymphocyte to Monocyte Ratio: A New Independent Prognostic Factor in Bladder Cancer Progression?
- (2021) Matteo Ferro et al. Frontiers in Oncology
- The preoperative neutrophil‐to‐lymphocyte ratio is not a marker of prostate cancer characteristics but is an independent predictor of biochemical recurrence in patients receiving radical prostatectomy
- (2019) Zhi Cao et al. Cancer Medicine
- Systemic immune-inflammation index, serum albumin, and fibrinogen impact prognosis in castration-resistant prostate cancer patients treated with first-line docetaxel
- (2019) Ya-nan Man et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Prognostic utility of neutrophil-to-lymphocyte and platelets-to-lymphocyte ratio in predicting biochemical recurrence post robotic prostatectomy
- (2018) Marc Zanaty et al. Biomarkers in Medicine
- Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review
- (2018) Thomas Van den Broeck et al. EUROPEAN UROLOGY
- Systemic immune-inflammation index predicts the combined clinical outcome after sequential therapy with abiraterone and docetaxel for metastatic castration-resistant prostate cancer patients
- (2017) Liancheng Fan et al. PROSTATE
- Elevated preoperative neutrophil–lymphocyte ratio predicts upgrading at radical prostatectomy
- (2017) Mehmet Özsoy et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Neutrophil and Lymphocyte Counts as Clinical Markers for Stratifying Low-Risk Prostate Cancer
- (2016) Young Suk Kwon et al. Clinical Genitourinary Cancer
- Prognostic impact of preoperative neutrophil-to-lymphocyte ratio after radical prostatectomy in localized prostate cancer
- (2016) W S Jang et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer
- (2016) Alessandro Passardi et al. Oncotarget
- Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib
- (2016) Cristian Lolli et al. Oncotarget
- Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone
- (2016) Cristian Lolli et al. Frontiers in Pharmacology
- Pretreatment Neutrophil-to-Lymphocyte Ratio
- (2015) Gui-Ming Zhang et al. MEDICINE
- Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients
- (2015) Tanja Langsenlehner et al. WORLD JOURNAL OF UROLOGY
- High preoperative neutrophil–lymphocyte ratio predicts biochemical recurrence in patients with localized prostate cancer after radical prostatectomy
- (2015) Hakmin Lee et al. WORLD JOURNAL OF UROLOGY
- Neutrophil-to-lymphocyte ratio may be associated with the outcome in patients with prostate cancer
- (2015) Daniele Minardi et al. SpringerPlus
- Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma
- (2014) B. Hu et al. CLINICAL CANCER RESEARCH
- Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Men With Metastatic Castration-Resistant Prostate Cancer
- (2014) Guru Sonpavde et al. Clinical Genitourinary Cancer
- Platelets in cancer and thrombosis
- (2013) J. Riedl et al. Hamostaseologie
- Neutrophil-mediated tumour angiogenesis: Subversion of immune responses to promote tumour growth
- (2013) Simon Tazzyman et al. SEMINARS IN CANCER BIOLOGY
- Tumor markers in prostate cancer I: Blood-based markers
- (2011) Shahrokh F. Shariat et al. ACTA ONCOLOGICA
- The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma
- (2011) Daniel Keizman et al. EUROPEAN JOURNAL OF CANCER
- Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma
- (2008) Dhanwant Gomez et al. JOURNAL OF SURGICAL ONCOLOGY
- Neutrophil/lymphocyte ratio and its association with survival after complete resection in non–small cell lung cancer
- (2008) Khaled M. Sarraf et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started